| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/08/2011 | US7902401 Fluorinated compounds |
| 03/08/2011 | US7902399 Fatty acids analogous |
| 03/08/2011 | US7902378 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment |
| 03/08/2011 | US7902377 Method for preparing medetomidine and its salts |
| 03/08/2011 | US7902375 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseases |
| 03/08/2011 | US7902372 Therapy for obesity; using a secondary amino compound |
| 03/08/2011 | US7902369 Diaryl-substituted five-membered heterocycle derivative |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902361 Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy |
| 03/08/2011 | US7902360 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 03/08/2011 | US7902358 Gastrointestinal disorders; inflammatory bowel disorders; gastroesophageal reflux, constipation; diarrhea |
| 03/08/2011 | US7902349 Nucleic acids encoding protective epitopes of adenyl cyclase-haemolysin (AC-Hly) |
| 03/08/2011 | US7902327 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 03/08/2011 | US7902261 Use of fingolimod or salt |
| 03/08/2011 | US7902260 Using a retinoid such as 4-((5,6,7,8-tetrahydro-5,5,8,8-tetramethylnaphthalenyl)carbamoyl)benzoic acid |
| 03/08/2011 | US7902259 with zinc-binding activities; 5-phenyl-2,4,-pentadienoyl hydroxamic acid; gene expression inhibitor; anticarcinogenic, antitumor, antiprotozoa agent, viricide; hematological disorders, hemoglobinopathies, genetic related metabolic disorders, cystic fibrosis |
| 03/08/2011 | US7902258 Preventing lesions associated with herpes virus by topically administering a C1 to C3 monohydroxy alcohol or C3 to C4 diol and a sufficient amount of an acid to adjust the pH to below 4.6 |
| 03/08/2011 | US7902255 γ-butyrolactone compound and pharmaceutical composition thereof |
| 03/08/2011 | US7902254 Method for treating conditions mediated by PPAR using macelignan |
| 03/08/2011 | US7902253 Isoflavone derivatives of tectorigenin, the preparation thereof and the antiviral medicine containing the same as an effective constituent |
| 03/08/2011 | US7902252 Inhibitors of D-amino acid oxidase |
| 03/08/2011 | US7902251 Method for treating pain |
| 03/08/2011 | US7902250 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 03/08/2011 | US7902249 Central nervous system disorders; oxidation resistance; antitumor agents; Alzheimer's disease; 3-(2-hydroxyethyl)indole |
| 03/08/2011 | US7902248 Oxime glucokinase activators |
| 03/08/2011 | US7902247 Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors |
| 03/08/2011 | US7902246 Methods for controlling formation of imiquimod impurities for two months, four months, and six months |
| 03/08/2011 | US7902245 Methods for reducing imiquimod impurities for two months, four months, and six months |
| 03/08/2011 | US7902244 Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation (at least four months storage) |
| 03/08/2011 | US7902243 Methods for improving imiquimod availability at two months, four months and six months between refined and compendial |
| 03/08/2011 | US7902242 Method of stabilizing imiquimod |
| 03/08/2011 | US7902241 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 03/08/2011 | US7902240 Substituted pyrazole and triazole compounds as KSP inhibitors |
| 03/08/2011 | US7902239 Diaminotriazoles useful as inhibitors of protein kinases |
| 03/08/2011 | US7902238 2-aminooxazolines as TAAR1 ligands |
| 03/08/2011 | US7902237 nuclear receptor activity modulators; 4-(ethylamino)-3-{[(2Z,5Z)-5-{[methyl(phenyl)amino]methylidene}-4-oxo-3-(phenylmethyl)-1,3-thiazolidin-2-ylidene]amino}benzonitrile; diseases or disorders affected by abnormal cholesterol, triglyceride, or bile acid levels |
| 03/08/2011 | US7902236 Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof |
| 03/08/2011 | US7902235 Compounds for nonsense suppression, and methods for their use |
| 03/08/2011 | US7902234 Thiadiazoline derivative |
| 03/08/2011 | US7902233 Compounds useful as pesticides |
| 03/08/2011 | US7902232 Substituted arylpyrazoles |
| 03/08/2011 | US7902230 Benzimidazole derivatives and their use for modulating the GABAA receptor complex |
| 03/08/2011 | US7902229 Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| 03/08/2011 | US7902228 Schweinfurthin analogues |
| 03/08/2011 | US7902227 C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents |
| 03/08/2011 | US7902226 Dehalogeno-compounds |
| 03/08/2011 | US7902225 Mycobacterial inhibitors |
| 03/08/2011 | US7902224 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators |
| 03/08/2011 | US7902223 Phenyl derivatives as factor XA inhibitors |
| 03/08/2011 | US7902222 Biaryl substituted azabicyclic alkane derivatives |
| 03/08/2011 | US7902221 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 03/08/2011 | US7902220 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists |
| 03/08/2011 | US7902219 2-benzoylimidazopyridine derivatives, preparation and therapeutic use thereof |
| 03/08/2011 | US7902218 Inhibit production of A beta -peptide; neurological disorders, Alzheimer's disease; (S)-2-((S)-3-Acetamido-3-((R)-sec-butyl)-2-oxopyrrolidin-1-yl)-N-((1R,2S)-3-(3,5-difluorophenyl)-1-hydroxy-1-((R)-1,2,3,4-tetrahydroisoquinolin-3-yl)propan-2-yl)-4-phenylbutanamide |
| 03/08/2011 | US7902217 Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 03/08/2011 | US7902208 Treating allergic and inflammatory conditions |
| 03/08/2011 | US7902206 Polymorphic forms α, β and γ of rifaximin |
| 03/08/2011 | US7902205 Purinone derivatives as HM74A agonists |
| 03/08/2011 | US7902204 2-(4-Benzoyl-piperazin-1-yl)-3-(4-chloro-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-3-oxo-propionitrile; HIV and AIDS |
| 03/08/2011 | US7902202 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 03/08/2011 | US7902201 Isoxazolo-pyrazine derivatives |
| 03/08/2011 | US7902200 Chemical compounds |
| 03/08/2011 | US7902199 Heterocyclic substituted piperazine compounds with CXCR3 antagonist activity |
| 03/08/2011 | US7902198 Crystalline aripiprazole solvates |
| 03/08/2011 | US7902197 Pyrrolopyrazine kinase inhibitors |
| 03/08/2011 | US7902196 Synthesis of avrainvillamide, strephacidin B, and analogues thereof |
| 03/08/2011 | US7902195 Pyridine [3,4-b] pyrazinones |
| 03/08/2011 | US7902194 7-Dimethylamino-3-(2-methyl-3-{1-methyl-5-[5-(morpholine-4-carbonyl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-pyridin-3-yl}-phenyl)-3H-quinazolin-4-one; asthma ; inhibit Btk |
| 03/08/2011 | US7902193 Phthalazinone derivatives |
| 03/08/2011 | US7902192 Inhibitors of P38 and methods of using the same |
| 03/08/2011 | US7902191 Histamine H3 receptor antagonists, preparation and therapeutic uses |
| 03/08/2011 | US7902190 Indol derivatives, the method for preparing thereof and composition for the prevention and treatment of metabolic disorder containing the same as an active ingredient |
| 03/08/2011 | US7902189 Compounds |
| 03/08/2011 | US7902188 Morpholine dopamine agonists |
| 03/08/2011 | US7902187 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 03/08/2011 | US7902186 Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-1,3,4-thiadiazines |
| 03/08/2011 | US7902185 Treatment of neurodegenerative diseases using proteasome modulators |
| 03/08/2011 | US7902184 Piperazinyl pyrimidine derivatives |
| 03/08/2011 | US7902183 Thiazolyl-dihydro-indazole |
| 03/08/2011 | US7902182 HIV integrase inhibitors |
| 03/08/2011 | US7902181 Compounds 010 |
| 03/08/2011 | US7902180 Association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it |
| 03/08/2011 | US7902179 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease |
| 03/08/2011 | US7902177 Treatment of congestion using steroids and adrenergics |
| 03/08/2011 | US7902176 Etherified oxidized phospholipids for inducing tolerance to oxidized LDL via mucosal administration; 1-hexadecyl-2-(5'-oxo-pentanyl)-sn-glycero-3-phosphocholine (D-ALLE) |
| 03/08/2011 | US7902175 Aminopropanol derivatives |
| 03/08/2011 | US7902174 Antiviral composition |
| 03/08/2011 | US7902173 Compound selected from sulfated cellulose and salts thereof and dermatitis therapeutic agent |
| 03/08/2011 | US7902172 Method of promoting bone growth with hyaluronic acid and growth factors |
| 03/08/2011 | US7902171 Composition for treating inflammatory diseases |
| 03/08/2011 | US7902170 Influenza virus binding, sialylated oligosaccharide substance and use thereof |
| 03/08/2011 | US7902169 Methods and compositions for the treatment of eye disorders with increased intraocular pressure |
| 03/08/2011 | US7902168 Compositions and methods for inhibiting expression of Nav1.8 gene |
| 03/08/2011 | US7902167 Compounds and methods for down-regulating Wrap53 protein by RNA interference |
| 03/08/2011 | US7902166 Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same |
| 03/08/2011 | US7902164 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/08/2011 | US7902163 Antisense modulation of superoxide dismutase 1, soluble expression |
| 03/08/2011 | US7902162 Medicament and method for treating recurrent spontaneous abortion |
| 03/08/2011 | US7902161 Oligonucleotides derived from mycobacterium for stimulating immune function, treating immune-related diseases, atopic dermatitis and/or protecting normal immune cell |
| 03/08/2011 | US7902160 ENA nucleic acid drugs modifying splicing in mRNA precursor |